Pilot Study - Monitoring the Nasal Microbiome and Viral Respiratory Infections in Newborn Hospitalized in Neonatalogy.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

38 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-12-21

Study Completion Date

2024-11-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of our study is therefore to study the evolution of the respiratory microbiome of hospitalized newborns, its interaction with viral infections and their impacts on the evolution of newborns.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Follow-up of the Nasal Microbiome and Viral Infections in Newborns Hospitalised in Neonatology.

NCT05717283

Microbial Colonization Viral Infection Neonatal Infection

COMPLETED NA

New Dosages of Inflammatory Markers for the Early Diagnosis of Nosocomial Bacterial Infections of the Newborn

NCT00701948

Nosocomial Infection

COMPLETED

Integrative Approach to Identify Environmental Risk Factors for CC-17 Group B Streptococcal Neonatal Infection

NCT02471937

Vaginal Colonization With GBS

COMPLETED NA

Diagnostic Performance Comparison Between Procalcitonin-based vs. ANAES-based Guidelines

NCT02590198

Early-onset Neonatal Infection

COMPLETED

Dynamics of the Microbiome in the Premature Infant

NCT02121938

Infection

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Newborn; Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Nasal swab

* Nasal swab once a week for the duration of the stay in intensive care unit/intensive care (procedure already carried out routinely to detect nasal staphylococcus once a week).
* Nasal swab every 14 days when the newborn is hospitalized in routine care/kangaroo unit/hospitalization at home

Group Type OTHER

Nasal Swab

Intervention Type OTHER

* Nasal swab once a week for the duration of the stay in intensive care unit/intensive care (procedure already carried out routinely to detect nasal staphylococcus once a week).
* Nasal swab every 14 days when the newborn is hospitalized in routine care/kangaroo unit/hospitalization at home

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nasal Swab

* Nasal swab once a week for the duration of the stay in intensive care unit/intensive care (procedure already carried out routinely to detect nasal staphylococcus once a week).
* Nasal swab every 14 days when the newborn is hospitalized in routine care/kangaroo unit/hospitalization at home

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Newborn hospitalized in intensive care or neonatal intensive care.
* Whose parents were able to be informed of the study and who signed consent.
* Parents affiliate to the social security system

Exclusion Criteria

* Refusal of parental consent
* Parents who are minors or under guardianship, curatorship, safeguard of justice or legal protection.
* Newborn having already left the hospital/returned home before inclusion
* Hospitalization beyond the first 48 hours of life
* Only palliative care.

Eligible Sex

ALL

Accepts Healthy Volunteers

No